Literature DB >> 26697674

Progress on mechanism of Tripterygium wilfordii-induced liver injury and detoxification mechanism of licorice.

Ling-juan Cao, Miao Yan, Huan-de Li, Bi-kui Zhang, Ping-fei Fang.   

Abstract

Tripterygium wilfordii has exihibited multiple pharmacological activities, such as anti-inflammatory, immune modulation, anti-tumor and anti-fertility. T. wilfordii have been used for the therapy of inflammation and autoimmune diseases including rheumatoid arthritis, immune complex nephritis and systemic lupus erythematosus clinically. However, it is well known that T. wilfordii has small margin between the therapeutic and toxic doses and could cause serious injury on digestive, reproductive and urogenital systems. Among all the organs, liver is one of the most remarkable targets of T. wilfordii-induced toxicities, and the damage is more serious than others. It is generally accepted that T. wilfordii-induced liver injury is a result of the combined effects of toxic elements of T. wilfordii. It is reported in several studies that the mechanism of T. wilfordii-induced liver injury may be related to lipid peroxidation, cell apoptosis and immune damage, and so on. Licorice is one of the most commonly used Chinese herbal medicine, with effects of heat- clearing and detoxicating, anti-inflammatory and hepatoprotective, reconciling various drugs, and so on. Licorice often accompany T. wilfordii in clinical application which can significantly reduce the liver injury induced by T. wilfordii. The attenuated effect is exact, but the mechanism is still a lack of in-depth study. This paper reviews the studies on T. wilfordii-induced liver injury and the related mechanism as well as licorice and other traditional Chinese medicine accompany T. wilfordii to reduce the injury in recent years, so as to provide reference for related research in the future.

Entities:  

Mesh:

Year:  2015        PMID: 26697674

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  7 in total

Review 1.  Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects.

Authors:  Cong-Ying Song; Ying-Ge Xu; Yuan-Qiang Lu
Journal:  J Zhejiang Univ Sci B       Date:  2020 Apr.       Impact factor: 3.066

Review 2.  A Systematic Review about the Efficacy and Safety of Tripterygium wilfordii Hook.f. Preparations Used for the Management of Rheumatoid Arthritis.

Authors:  Jing Wang; Na Chen; Liang Fang; Zhe Feng; Guochun Li; Attilio Mucelli; Xu Zhang; Xueping Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-08       Impact factor: 2.629

3.  Licorice root extract and magnesium isoglycyrrhizinate protect against triptolide-induced hepatotoxicity via up-regulation of the Nrf2 pathway.

Authors:  Qin-You Tan; Qian Hu; Sheng-Nan Zhu; Lu-Lu Jia; Juan Xiao; Hua-Zhen Su; Shao-Yuan Huang; Jing Zhang; Junfei Jin
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

Review 4.  Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis.

Authors:  Liu Liu; Huaibo Zhao; Xiaoying Sun; Qi Zheng; Ying Luo; Yi Ru; Ying Zhang; Xi Chen; Bo Zhu; Chengqian Yin; Bin Li; Xin Li
Journal:  BMC Complement Altern Med       Date:  2018-08-31       Impact factor: 3.659

5.  Detoxication mechanisms of Radix Tripterygium wilfordii via compatibility with Herba Lysimachia christinae in S180-bearing mice by involving Nrf2.

Authors:  Jun-Ming Wang; Hong Cai; Jin-Hua Li; Rong-Xing Chen; Yue-Yue Zhang; Jin-Yang Li; Ning-Ning Ding; Chen Liu; Ying Cui
Journal:  Biosci Rep       Date:  2018-07-12       Impact factor: 3.840

6.  Clinical Efficacy of Integrated Traditional Chinese and Western Medicine in the Treatment of Eczema: A Meta-Analysis.

Authors:  Xingxing Wang; Jian Meng; Qing Wu; Jingjing Feng; Huiling Jing
Journal:  Comput Math Methods Med       Date:  2022-03-03       Impact factor: 2.238

7.  Protective Effect of 18β-Glycyrrhetinic Acid against Triptolide-Induced Hepatotoxicity in Rats.

Authors:  Guanghua Yang; Lan Wang; Xiuting Yu; Yanfeng Huang; Chang Qu; Zhenbiao Zhang; Dandan Luo; Ji Lin; Lian Zhou; Ziren Su; Xiaojun Zhang; Haiming Chen
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-09       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.